Determinants of objective and subjective quality of life in first-time-admission schizophrenic patients in Poland: a longitudinal study

2007 ◽  
Vol 17 (2) ◽  
pp. 237-247 ◽  
Author(s):  
Krystyna Górna ◽  
Krystyna Jaracz ◽  
Filip Rybakowski ◽  
Janusz Rybakowski
1999 ◽  
Vol 14 (5) ◽  
pp. 256-263 ◽  
Author(s):  
A. Bengtsson-Tops ◽  
L. Hansson

SummaryThe aims of this study were to assess the quality of life among 120 schizophrenic patients who were attending a psychiatric outpatient department and to investigate which socio-demographic and clinical factors influenced their subjective quality of life. Quality of life was assessed by the Lanchashire quality of life profile, social functioning was judged according to the Global Assessment of Functioning (GAF) scale, and psychopathology was rated by means of the Brief Psychiatric Rating Scale (BPRS). Both objective and subjective life conditions indicated an impaired quality of life for the patients. The areas of finance and work had the largest proportion of dissatisfied patients. Socio-demographic indicators showed to have a weak influence on the patient's self-assessed quality of life while clinical factors, such as psychopathology, strongly influenced the patient's life satisfaction. It is concluded that there is a need for further emphasise on the clinical, financial, and social interventions for this group of patients.


2019 ◽  
Vol 10 ◽  
Author(s):  
Xiao Wei Tan ◽  
Shazana Shahwan ◽  
Pratika Satghare ◽  
Boon Yiang Chua ◽  
Swapna Verma ◽  
...  

1997 ◽  
Vol 170 (5) ◽  
pp. 422-425 ◽  
Author(s):  
M. Franz ◽  
Stefanie Lis ◽  
K. Plüddemann ◽  
B. Gallhofer

BackgroundThe effectiveness of anti-psychotic drugs against positive psychotic symptoms has been demonstrated in many studies, but their effects on quality of life have yet to be clarified. The impact of different neuroleptic therapies on the subjective quality of life of schizophrenic patients is evaluated in a cross-sectional open study.MethodDuring a four-month period a standardised quality of life interview for schizophrenic patients was applied on day 10 after admission; 33 patients on atypical neuroleptics (AAP) were compared with 31 matched patients on conventional neuroleptics (CAP).ResultsThe AAP group had significantly higher scores in general quality of life as well as in different life domains: physical well-being, social life and everyday life. In separate comparisons of the AAP group, patients on clozapine and risperidone were found to have a higher quality of life score than patients on CAP or zotepine.ConclusionsThe pharmacological profile of clozapine and risperidone may provide a basis for explaining the higher subjective quality of life found in this study. The lower quality of life of the CAP group may possibly be related to intrinsic effects of the conventional antipsychotics.


2003 ◽  
Vol 108 (4) ◽  
pp. 297-303 ◽  
Author(s):  
G. Reine ◽  
C. Lançon ◽  
S. Di Tucci ◽  
C. Sapin ◽  
P. Auquier

1999 ◽  
Vol 45 (4) ◽  
pp. 247-258 ◽  
Author(s):  
Lars Hansson ◽  
Thomas Middelboe ◽  
Lars Merinder ◽  
Olafur Bjarnason ◽  
Anita Bengtsson-Tops ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document